Krebs Biochemicals & Industries Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 963.36 compared to INR 756.72 a year ago. Net loss was INR 826.02 compared to INR 728.11 a year ago. Basic loss per share from continuing operations was INR 4.21 compared to INR 4.6 a year ago. For the nine months, total revenue was INR 3,801.83 compared to INR 1,892.38 a year ago. Net loss was INR 2,137.2 compared to INR 2,271.48 a year ago. Basic loss per share from continuing operations was INR 10.89 compared to INR 14.3 a year ago. Diluted loss per share from continuing operations was INR 12.12 compared to INR 14.3 a year ago.